Author

Sharad Singh

Institute of Life SciencesORCID 0000-0002-2518-9247Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Soma ChattopadhyayiD· 2 shared Bharat Bhusan SubudhiiD· 1 shared Bijita BhowmickiD· 1 shared Chandan MahishiD· 1 shared Harshit Borasi· 1 shared Kaustuv MukherjeeiD· 1 shared Kshyama Subhadarsini TungiD· 1 shared Mahendra GauriD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Soma ChattopadhyayORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Neuropilin-1 functions as a proviral and immunoregulatory host factor during Chikungunya virus infection

Kshyama Subhadarsini Tung, Chandan Mahish, Soumyajit Ghosh, Kaustuv Mukherjee, Sharad Singh, Bijita Bhowmick, Somlata Khamaru, Harshit Borasi, Mahendra Gaur, Bharat Bhusan Subudhi, Soma Chattopadhyay, Subhasis Chattopadhyay

This study identifies Neuropilin-1 as a host factor that promotes Chikungunya virus infection while restraining proinflammatory cytokine production, and shows its inhibition reduces viral infection in vitro and in vivo.

bioRxiv · Jul 27, 2026 · PreprintImmunology

Repurposing efavirenz, the HIV antiretroviral drug for Chikungunya virus infection.

Sanketkumar Nehul, Ruchi Rani, Priyanshu Walia, Prasan Kumar Panda, Sharad Singh, Soma Chattopadhyay, Pravindra Kumar, Shailly Tomar

This study identifies efavirenz's anti-CHIKV activity and shows it inhibits viral replication by targeting minus-sense RNA synthesis, suggesting its repurposing for antiviral therapy.

ACS Infectious Diseases · Mar 7, 2025Peer-reviewedMolecular Biology